1-3 of 3
Shekman Wong
Close
Sort by
Journal Articles

An Enterohepatic Recirculation Population Pharmacokinetic and MIC-1 Pharmacokinetic-Pharmacodynamic Model for the MDM2 Inhibitor Navtemadlin (KRT-232) in Healthy Subjects

Lu Zhang, Bill Poland, Michelle Green, Shekman Wong, J. Greg Slatter
Journal: Blood
Blood (2021) 138 (Supplement 1): 4350.
https://doi.org/10.1182/blood-2021-145205
Published: 2021
Journal Articles

Effect of Food on MDM2 Inhibitor KRT-232 Pharmacokinetics and Macrophage Inhibitory Cytokine-1 (MIC-1) Response in Healthy Volunteers

Shekman Wong, PhD, Cecile Marie Krejsa, PhD, Dana Lee, PharmD, Anna Harris, Emilie Simard, MSc, Xiaohui Wang, Igor Rubets, PhD, Martine Allard, PharmD, PhD, Terry Podoll, PhD, Terry O'Reilly, MD, J. Greg Slatter, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-135985
Published: 2020
Journal Articles

A Dose-Escalation Study of Venetoclax (ABT-199/GDC-0199) in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma

Sven de Vos, MD PhD, Lode Swinnen, MD, Mark Kozloff, MD, Ding Wang, MD PhD, Erin Reid, MD, Loretta Nastoupil, MD, Nathan Fowler, MD, Jaclyn Cordero, Diane D'Amico, Susan Diehl, Martin Dunbar, DrPH, Ming Zhu, PhD, Shekman Wong, PhD, Sari Heitner Enschede, MD, David Chien, MD, Rod A. Humerickhouse, MD PhD, Christopher Flowers, MD
Journal: Blood
Blood (2015) 126 (23): 255.
https://doi.org/10.1182/blood.V126.23.255.255
Published: 2015